Apr 27, 2010 2:00 PM by Bea Karnes, News First 5
The University of Colorado at Boulder has received a $15 million grant through the American Recovery and Reinvestment Act to be used toward the ongoing construction of a biotechnology and biomedical research facility.
Faculty and students will use the facility for fundamental research on everything from cancer and cardiovascular disease to vaccine development and regenerative medicine.
The money was awarded to CU-Boulder's Colorado Initiative in Molecular Biotechnology, or CIMB, through the National Institutes of Health, an agency of the U.S. Department of Health and Human Services. The first phase of the building is slated for completion in fall 2011.
"This is such an appropriate use of ARRA funds, because the Biotechnology Building will create jobs at three stages - construction jobs in the near term, laboratory research positions once the building is occupied, and biotechnology jobs in Colorado over the following years as we work to enhance that industry in the state," said Tom Cech, CU-Boulder Distinguished Professor and CIMB Director.
Cech shared the 1989 Nobel Prize in chemistry.
In addition to interdisciplinary collaboration involving faculty and students, the modern equipment in the facility will give biotech companies the chance to come in and work with CU-Boulder faculty and students. It also will help CU build on its distinguished record in biotechnology research, which has generated more than a dozen biotech startup companies and currently attracts tens of millions of dollars annually in sponsored research awards.